The prognostic role of quality of life assessment in breast cancer

Breast Journal

Volumn 17, Issue 6, 2011, Pages 571-578

  Staren, Edgar D ^a   Gupta, Digant ^a   Braun, Donald P ^a  

^a CANCER TREATMENT CENTERS OF AMERICA   (United States)

Author keywords

breast cancer; prognosis; quality of life

Indexed keywords

ADULT; AGE; ARTICLE; BREAST CANCER; CANCER PATIENT; CANCER STAGING; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MEDICAL HISTORY; OVERALL SURVIVAL; PREDICTION; PROGNOSIS; QUALITY OF LIFE; RATING SCALE;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; QUALITY OF LIFE;

EID: 80755175848     PISSN: 1075122X     EISSN: 15244741     Source Type: Journal    
DOI: 10.1111/j.1524-4741.2011.01151.x     Document Type: Article

References (30)

1. Blazeby JM, Brookes ST, Alderson D,. Prognostic value of quality of life scores in patients with oesophageal cancer. Br J Surg 2000; 87: 362-73.
2. Coates A, Gebski V, Signorini D, et al. Prognostic value of quality-of-life scores during chemotherapy for advanced breast cancer. Australian New Zealand Breast Cancer Trials Group. J Clin Oncol 1992; 10: 1833-8. (Pubitemid 23064193)
3. Coates A, Porzsolt F, Osoba D,. Quality of life in oncology practice: prognostic value of EORTC QLQ-C30 scores in patients with advanced malignancy. Eur J Cancer 1997; 33: 1025-30. (Pubitemid 27310776)
4. Coates AS, Hurny C, Peterson HF, et al. Quality-of-life scores predict outcome in metastatic but not early breast cancer. International Breast Cancer Study Group. J Clin Oncol 2000; 18: 3768-74.
5. Collette L, van Andel G, Bottomley A, et al. Is baseline quality of life useful for predicting survival with hormone-refractory prostate cancer? A pooled analysis of three studies of the European Organisation for Research and Treatment of Cancer Genitourinary Group. J Clin Oncol 2004; 22: 3877-85. (Pubitemid 41079868)
6. Dancey J, Zee B, Osoba D, et al. Quality of life scores: an independent prognostic variable in a general population of cancer patients receiving chemotherapy. The National Cancer Institute of Canada Clinical Trials Group. Qual Life Res 1997; 6: 151-8. (Pubitemid 27207280)
7. Dharma-Wardene M, Au HJ, Hanson J, Dupere D, Hewitt J, Feeny D,. Baseline FACT-G score is a predictor of survival for advanced lung cancer. Qual Life Res 2004; 13: 1209-16. (Pubitemid 39157332)
8. Earlam S, Glover C, Fordy C, Burke D, Allen-Mersh TG,. Relation between tumor size, quality of life, and survival in patients with colorectal liver metastases. J Clin Oncol 1996; 14: 171-5. (Pubitemid 26020010)
9. Efficace F, Biganzoli L, Piccart M, et al. Baseline health-related quality-of-life data as prognostic factors in a phase III multicentre study of women with metastatic breast cancer. Eur J Cancer 2004; 40: 1021-30. (Pubitemid 38496258)
10. Fang FM, Liu YT, Tang Y, Wang CJ, Ko SF,. Quality of life as a survival predictor for patients with advanced head and neck carcinoma treated with radiotherapy. Cancer 2004; 100: 425-32. (Pubitemid 38063655)
11. Fang FM, Tsai WL, Chiu HC, Kuo WR, Hsiung CY,. Quality of life as a survival predictor for esophageal squamous cell carcinoma treated with radiotherapy. Int J Radiat Oncol Biol Phys 2004; 58: 1394-404.
12. Kramer JA, Curran D, Piccart M, et al. Identification and interpretation of clinical and quality of life prognostic factors for survival and response to treatment in first-line chemotherapy in advanced breast cancer. Eur J Cancer 2000; 36: 1498-506. (Pubitemid 30619002)
13. Langendijk H, Aaronson NK, de Jong JM, ten Velde GP, Muller MJ, Wouters M,. The prognostic impact of quality of life assessed with the EORTC QLQ-C30 in inoperable non-small cell lung carcinoma treated with radiotherapy. Radiother Oncol 2000; 55: 19-25. (Pubitemid 30219430)
14. Luoma ML, Hakamies-Blomqvist L, Sjostrom J, et al. Prognostic value of quality of life scores for time to progression (TTP) and overall survival time (OS) in advanced breast cancer. Eur J Cancer 2003; 39: 1370-6. (Pubitemid 36773779)
15. Maisey NR, Norman A, Watson M, Allen MJ, Hill ME, Cunningham D,. Baseline quality of life predicts survival in patients with advanced colorectal cancer. Eur J Cancer 2002; 38: 1351-7. (Pubitemid 34686846)
16. Montazeri A, Milroy R, Hole D, McEwen J, Gillis CR,. Quality of life in lung cancer patients: as an important prognostic factor. Lung Cancer 2001; 31: 233-40. (Pubitemid 32107019)
17. Roychowdhury DF, Hayden A, Liepa AM,. Health-related quality-of-life parameters as independent prognostic factors in advanced or metastatic bladder cancer. J Clin Oncol 2003; 21: 673-8. (Pubitemid 46621902)
18. Tamburini M, Brunelli C, Rosso S, Ventafridda V,. Prognostic value of quality of life scores in terminal cancer patients. J Pain Symptom Manage 1996; 11: 32-41. (Pubitemid 26046083)
19. Herndon JE, Fleishman S, Kornblith AB, Kosty M, Green MR, Holland J,. Is quality of life predictive of the survival of patients with advanced nonsmall cell lung carcinoma? Cancer 1999; 85: 333-40. (Pubitemid 29051287)
20. Efficace F, Therasse P, Piccart MJ, et al. Health-related quality of life parameters as prognostic factors in a nonmetastatic breast cancer population: an international multicenter study. J Clin Oncol 2004; 22: 3381-8. (Pubitemid 41103697)
21. Groenvold M, Petersen MA, Idler E, Bjorner JB, Fayers PM, Mouridsen HT,. Psychological distress and fatigue predicted recurrence and survival in primary breast cancer patients. Breast Cancer Res Treat 2007; 105: 209-19. (Pubitemid 47366885)
22. Gupta D, Granick J, Grutsch JF, Lis CG,. The prognostic association of health-related quality of life scores with survival in breast cancer. Support Care Cancer 2007; 15: 387-93. (Pubitemid 46697017)
23. Lehto US, Ojanen M, Dyba T, Aromaa A, Kellokumpu-Lehtinen P,. Baseline psychosocial predictors of survival in localised breast cancer. Br J Cancer 2006; 94: 1245-52.
24. Seidman AD, Portenoy R, Yao TJ, et al. Quality of life in phase II trials: a study of methodology and predictive value in patients with advanced breast cancer treated with paclitaxel plus granulocyte colony-stimulating factor. J Natl Cancer Inst 1995; 87: 1316-22.
25. Shimozuma K, Sonoo H, Ichihara K, Tanaka K,. The prognostic value of quality-of-life scores: preliminary results of an analysis of patients with breast cancer. Surg Today 2000; 30: 255-61. (Pubitemid 30187219)
26. Winer EP, Berry DA, Woolf S, et al. Failure of higher-dose paclitaxel to improve outcome in patients with metastatic breast cancer: cancer and leukemia group B trial 9342. J Clin Oncol 2004; 22: 2061-8. (Pubitemid 41095138)
27. Osoba D, Rodrigues G, Myles J, Zee B, Pater J,. Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol 1998; 16: 139-44. (Pubitemid 28041591)
28. Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993; 85: 365-76. (Pubitemid 23073154)
29. Groenvold M, Klee MC, Sprangers MA, Aaronson NK,. Validation of the EORTC QLQ-C30 quality of life questionnaire through combined qualitative and quantitative assessment of patient-observer agreement. J Clin Epidemiol 1997; 50: 441-50. (Pubitemid 27223274)
30. Hjermstad MJ, Fossa SD, Bjordal K, Kaasa S,. Test/retest study of the European Organization for Research and Treatment of Cancer Core Quality-of-Life Questionnaire. J Clin Oncol 1995; 13: 1249-54.